Trandate, Injektionslösung

7680415290161 CH-41529 Injektionslösung
Trandate, Injektionslösung
Trandate, Injektionslösung
Trandate, Injektionslösung
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/10/2023
Summary of Product Characteristics
Français
05/10/2023
Summary of Product Characteristics
Italien
05/10/2023

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
acidum hydrochloridum dilutum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
(N/A)
- Substance HNIDK
natrium
0.182 MG Substance HBESI

Authorization holder

Aspen Pharma Schweiz GmbH

6340 Baar

Authorization information

Swissmedic authorization number
41529
Drug name
Trandate, Injektionslösung
Galenic form
LSPA
ATC Code
C07AG01
Authorization status
Z
Dispensing category
B
First authorization
23/10/1979
Authorization expiration date
31/12/9999
IT Number
02.03.0.
Domain
Human medicine
Field of application
Alpha- und Beta-Rezeptorenblocker

Package details

Description (FR)
TRANDATE sol inj 100 mg/20ml 5 amp 20 ml
Description (DE)
TRANDATE Inj Lös 100 mg/20ml 5 Amp 20 ml
Market launch
23/10/1979
Narcotic (BTM)
No